reports
- Hybridan Team
Hybridan Small Cap Feast: 05/06/2025
Our daily digest of news from UK Small Caps 5th June 2025 @HybridanLLP * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) or similar announcement has been made ***Arranged by type of listing and date of announcement ****Alphabetically arranged Dish of the day Admissions: Delistings: G3 Exploration (G3E.L) has left the Main Market. What’s baking in the oven? Potential** Initial Public Offerings...
- Hybridan Team
Hybridan Small Cap Feast: 15/05/2025
Our daily digest of news from UK Small Caps 15th May 2025 @HybridanLLP * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) or similar announcement has been made ***Arranged by type of listing and date of announcement ****Alphabetically arranged Dish of the day Admissions: None Delistings: Alliance Pharma (APH.L) and Zytronic (ZYT.L) delisted today from AIM. What’s baking in the oven? Potential** Init...
- Hybridan Team
- Jon Levinson
Hybridan Monthly 1 May 2025
Hybridan Monthly, 1 May 2025 Market Comment: A contrarian view to companies delisting from the market The flurry of companies delisting from the market has accelerated since early 2024. The London Stock Exchange (“LSE”) has been an easy target for those eager to point the blame. Unfortunately, criticism towards the LSE is now synonymous with the media coverage of a company leaving the market. “The London Stock Exchange is on course for its worst year for departures since the financial crisis….” ...
- Hybridan Team
- Jon Levinson
Friday Take Away: 11 April 2025
Friday Takeaway from UK Small Caps This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to raise awareness 11th April 2025 Alphabetically arranged Share prices and market capitalisations taken from Alpha Terminal from the current price on the day of publication. Top three shareholders are taken from the websites of the companies that we are writing about, unless there is a more up to date TR-1 notifi...
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 09/04/2025
Our daily digest of news from UK Small Caps @HybridanLLP 9th April 2025 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: Delistings: Synairgen (SNG.L) del...
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 19/02/2025
Our daily digest of news from UK Small Caps @HybridanLLP 19th February 2025 * A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: Delistings: Intelligent Ultrasou...
- Sean Conroy
Ondine Biomedical - Steriwave initiates UK pilot study with NHS
Ondine Biomedical has announced the initiation of its first NHS pilot study for Steriwave, the company’s lead product for nasal photodisinfection. The pilot is based at the Mid Yorkshire Teaching NHS Trust and will assess the effectiveness of Ondine’s technology in preventing surgical site infections (SSIs). The study will have a duration of six months and involve 500 hip and knee surgery patients using Steriwave for nasal decolonisation prior to surgery. With hospital-associated infections (HAI...
- Sean Conroy
Ondine Biomedical - Proprietary platform testing standard of care
Ondine Biomedical is focused on becoming a leader in tackling antimicrobial resistance (AMR) at the source, by leveraging its capabilities and proprietary platform technologies. The company specialises in the field of photodisinfection, a unique approach to preventing the spread of infections that uses light to destroy pathogens. Its lead product Steriwave was first approved by Health Canada, and Ondine has since partnered with HCA Healthcare, a leading US hospital group, to run US clinical tria...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.